Oscar Health (OSCR) Liabilities and Shareholders Equity (2020 - 2026)

Oscar Health has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $9.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 58.97% year-over-year to $9.3 billion; the trailing twelve-month figure through Mar 2026 stood at $27.7 billion (up 37.53% YoY), and the FY2025 full-year result was $6.3 billion, up 30.68% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $9.3 billion, up from $6.3 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $9.3 billion in Q1 2026, with the low at $3.3 billion in Q3 2023.
• Historically, Liabilities and Shareholders Equity has averaged $5.1 billion across 5 years, with a median of $4.6 billion in 2023.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity declined 22.26% — and 2026, when it surged 58.97%.
• Oscar Health's Liabilities and Shareholders Equity stood at $4.5 billion in 2022, then retreated by 20.44% to $3.6 billion in 2023, then soared by 34.4% to $4.8 billion in 2024, then surged by 30.68% to $6.3 billion in 2025, then soared by 46.86% to $9.3 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $9.3 billion (Q1 2026), $6.3 billion (Q4 2025), and $5.7 billion (Q3 2025), per Business Quant data.